$33.45
0.040.12%
가까이에: Aug 21, 5:00 PM EST
$33.70
0.250.75%
시간외: Aug 21, 6:17 PM EST
Benzinga
Benzinga
Benzinga
일요일, 8월 23
Genmab AS
GMABNASDAQ
Genmab Earnings & Forecasts
Genmab (GMAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Genmab Guidance
Genmab (GMAB)는 8월 6, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $4.33B - $4.53B 범위로 예상했습니다.
이전 가이던스와 비교하여 Genmab는 매출 전망치를 이전 범위인 상향 조정됨에서 $4.07B - $4.39B로 상향 조정했습니다.
Genmab은 17과 11월 3, 2022 사이에 8월 6, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 10 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.31 | $0.17 | $0.44 | $0.46 |
| Actual | $4.91 | $0.08 | $0.05 | $0.65 |
| Surprise | +1483.9% | -51.2% | -88.6% | +40.4% |
| Revenue | ||||
| Estimate | $5.81B | $4.71B | $4.40B | $4.21B |
| Actual | $1.16B | $896.0M | $1.06B | $1.02B |
| Surprise | -80.1% | -81.0% | -76.0% | -75.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.35 | $0.29 | $0.14 | $0.47 |
| Revenue | ||||
| Consensus | $6.57B | $6.66B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved